Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Head & Neck 2

Conditions

Drug-Related Side Effects and Adverse Reactions 10Head and Neck Neoplasms 9Radiation Injuries 7Lung Neoplasms 7Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Ovarian Epithelial 5Sarcoma 3Prostatic Neoplasms 3Neurotoxicity Syndromes 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia 3Hodgkin Disease 3Breast Neoplasms 3Xerostomia 2Waldenstrom Macroglobulinemia 2Urinary Bladder Neoplasms 2Testicular Neoplasms 2Small Cell Lung Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Neuroectodermal Tumors, Primitive, Peripheral 2Mucositis 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2

Interventions

Cisplatin 4angiotensin I (1-7) 3Radiotherapy 3Radiation 3Injections 3Water 2RRx-001 2Interleukin 1 Receptor Antagonist Protein 2Drug Therapy 2Amifostine 2tempol 1peppermint oil 1pegfilgrastim 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1glucarpidase 1fish oil triglycerides 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vaccinium myrtillus extract 1Tramadol 1Therapeutics 1Surgical Procedures, Operative 1Sorbic Acid 1Sodium Bicarbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Mucositis × Amifostine × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

NCT00095927 2017-01-04

Randomized Amifostine For SCCHN

Dana-Farber Cancer Institute

Phase 2 Completed
58 enrolled
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡